Springer Nature KGaA (SPGD) Stock Overview

Operates as a research, health, educational, and professional publisher worldwide. More details

SPGD fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	1/6
Past Performance	5/6
Financial Health	3/6
Dividends	0/6

Rewards

Trading at 62.1% below our estimate of its fair value

Earnings are forecast to grow 13.31% per year

Earnings grew by 294% over the past year

Analysts in good agreement that stock price will rise by 23.6%

Risk Analysis

Shares are highly illiquid

Has a high level of debt

SPGD Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Springer Nature AG & Co. KGaA Competitors

Price History & Performance

Summary of share price highs, lows and changes for Springer Nature KGaA
Historical stock prices
Current Share Price	€22.63
52 Week High	€23.53
52 Week Low	€22.63
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-3.83%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	SPGD	GB Media	GB Market
7D	0%	1.4%	1.8%
1Y	n/a	-17.6%	13.1%

Return vs Industry: Insufficient data to determine how SPGD performed against the UK Media industry.

Return vs Market: Insufficient data to determine how SPGD performed against the UK Market.

Price Volatility

Is SPGD's price volatile compared to industry and market?
SPGD volatility
SPGD Average Weekly Movement	n/a
Media Industry Average Movement	5.2%
Market Average Movement	4.7%
10% most volatile stocks in GB Market	10.8%
10% least volatile stocks in GB Market	2.4%

Stable Share Price: SPGD's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: Insufficient data to determine SPGD's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1842	9,200	Frank Peeters	www.springernature.com

Springer Nature AG & Co. KGaA operates as a research, health, educational, and professional publisher worldwide. It publishes science, technical, and medical content through journals under the Nature and Springer brand to research and academic research libraries, libraries of research-intensive institutions, libraries at government agencies, and corporate libraries; books in prints in various types, including monographs, textbooks, proceeding, handbook series, reference works, briefs, and others; and eBook formats, as well as offers books online under the Springer and Palgrave Macmillan brand for authors. The company offers research solutions, consisting of research authors and services, scientific discovery and expert database offerings and services, and other solutions for organizations.

Springer Nature AG & Co. KGaA Fundamentals Summary

How do Springer Nature KGaA's earnings and revenue compare to its market cap?
SPGD fundamental statistics
Market cap	€4.55b
Earnings (TTM)	€164.50m
Revenue (TTM)	€1.88b

27.7x

P/E Ratio

2.4x

P/S Ratio

Is SPGD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SPGD income statement (TTM)
Revenue	€1.88b
Cost of Revenue	€237.20m
Gross Profit	€1.64b
Other Expenses	€1.47b
Earnings	€164.50m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

Nov 12, 2025

Earnings per share (EPS)	0.83
Gross Margin	87.36%
Net Profit Margin	8.77%
Debt/Equity Ratio	85.4%

How did SPGD perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

16%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/10/07 05:56
End of Day Share Price	2025/09/23 00:00
Earnings	2025/06/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Springer Nature AG & Co. KGaA is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Nicholas Michael Dempsey	Barclays
Nicholas Michael Dempsey	Barclays
Sami Kassab	BNP Paribas Exane